In-Licensing

We support clients with start-to-finish solutions for production of biotherapeutics such as antibodies and vaccines. This includes offerings of cell media and single-use equipment for biopharmaceutical production as well as tools based on chromatography and filtration systems. Total single-use systems and turn-key enterprise solutions are also provided.

We are seeking:

• Protein expression technologies.
• Cell culture media.
• Automation, sensors, and software for process analysis.
• Chromatography resins and filtration devices for laboratory and manufacturing scale.
• Affinity ligands.
• Products and technologies that improve bioproduction processes.

The field of cell therapies has shown rapid growth in the industry over the past few years, driven by dramatic clinical results. With Cytiva’s strength in biomanufacturing, we are well positioned to enable progress in the industry by providing technologies and services to support the entire workflow.

We are seeking:

• Technologies or techniques along the entire cell therapy workflow, including cell isolation, selection, genetic modification, expansion, downstream processing, and analysis, back into a patient.
• Overall production scheduling and logistics planning and tracking tools.
• Opportunities to partner with large pharma in a broader collaboration model.

We provide instrumentation, assays, and tools for protein and cellular research to catalyze drug discovery and development. For example, we offer chromatography resins to support antibody and antibody fragment purification, and Biacore systems for label-free protein interaction analysis.

We are seeking:

• Reagents, consumables, and systems for protein expression, sample preparation, protein purification, identification, and analysis.
• Protein-protein interaction technologies, such as surface plasmon resonance.